Bamboos Health Care Holdings Limited (HKG:2293)
0.4000
0.00 (0.00%)
Oct 7, 2026, 3:16 PM HKT
HKG:2293 Ratios and Metrics
Market cap in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 161 | 151 | 201 | 250 | 300 | 332 | |
Market Cap Growth | -27.27% | -25.00% | -19.36% | -16.83% | -9.64% | 3.75% |
Enterprise Value | 184 | 169 | 182 | 233 | 287 | 358 |
Last Close Price | 0.40 | 0.38 | 0.49 | 0.56 | 0.60 | 0.59 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 25.81 | 24.21 | 11.47 | 8.07 | 6.39 | 5.66 |
PS Ratio | 2.41 | 2.26 | 2.68 | 2.61 | 2.35 | 2.35 |
PB Ratio | 0.65 | 0.61 | 0.88 | 1.14 | 1.35 | 1.58 |
P/TBV Ratio | 0.65 | 0.61 | 0.88 | 1.14 | 1.35 | 1.58 |
P/FCF Ratio | - | - | 5.51 | 6.98 | 7.20 | 3.31 |
P/OCF Ratio | - | - | 5.25 | 6.67 | 7.15 | 2.86 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 2.76 | 2.54 | 2.43 | 2.44 | 2.25 | 2.53 |
EV/EBITDA Ratio | 12.05 | 11.06 | 7.27 | 5.42 | 4.70 | 4.75 |
EV/EBIT Ratio | 13.98 | 12.82 | 7.94 | 5.61 | 4.80 | 4.83 |
EV/FCF Ratio | - | - | 4.99 | 6.51 | 6.90 | 3.57 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.24 | 0.24 | 0.27 | 0.29 | 0.31 | 0.33 |
Debt / EBITDA Ratio | 3.84 | 3.84 | 1.93 | 1.23 | 0.98 | 0.84 |
Debt / FCF Ratio | - | - | 1.70 | 1.78 | 1.64 | 0.69 |
Net Debt / Equity Ratio | 0.10 | 0.10 | 0.03 | -0.10 | -0.16 | -0.12 |
Net Debt / EBITDA Ratio | 1.53 | 1.53 | 0.32 | -0.53 | -0.58 | -0.33 |
Net Debt / FCF Ratio | - | - | 0.22 | -0.64 | -0.86 | -0.25 |
Asset Turnover | 0.21 | 0.21 | 0.24 | 0.29 | 0.37 | 0.48 |
Inventory Turnover | 33.23 | 33.23 | 31.00 | 23.06 | 19.59 | 28.99 |
Quick Ratio | 0.69 | 0.69 | 0.89 | 1.27 | 1.22 | 0.99 |
Current Ratio | 0.71 | 0.71 | 0.92 | 1.28 | 1.24 | 1.01 |
Return on Equity (ROE) | 2.62% | 2.62% | 7.84% | 14.03% | 21.68% | 28.92% |
Return on Assets (ROA) | 2.57% | 2.57% | 4.53% | 7.80% | 10.72% | 15.64% |
Return on Invested Capital (ROIC) | 3.22% | 3.43% | 8.30% | 17.12% | 25.71% | 43.19% |
Return on Capital Employed (ROCE) | 5.30% | 5.30% | 10.00% | 19.00% | 26.80% | 35.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 3.87% | 4.13% | 8.72% | 12.39% | 15.64% | 17.66% |
FCF Yield | - | - | 18.16% | 14.33% | 13.89% | 30.23% |
Dividend Yield | 6.25% | 6.67% | 8.24% | 13.41% | 12.58% | 12.73% |
Payout Ratio | - | - | 114.72% | 113.60% | 74.60% | 17.06% |
Buyback Yield / Dilution | -0.18% | -0.18% | -0.21% | -0.03% | - | - |
Total Shareholder Return | 6.07% | 6.49% | 8.04% | 13.38% | 12.58% | 12.73% |